Victor Shengkan Jin

Victor Shengkan Jin

Company: Mito BioPharma

Job title: Founder

Seminars:

Panel Discussion: Evaluate the Current Challenges in Targeting-Mitochondria for Chronic Mitochondrial Diseases 4:30 pm

How can drug developers/research cut to the real barriers? Debate what is truly required to break through to successful treatments for mitochondrial diseases Understand how to make good disease models in which one can test potential therapeutic pathwaysRead more

day: Day One

Mitochondrial Uncoupling for Therapeutic Development in Metabolic Diseases and Cancer 2:30 pm

Investigating how mitochondrial function deterioration is an important causal factor for several diseases, including NASH, type 2 diabetes, neurodegenerative diseases Exploring mitochondria-related metabolic changes (e.g. the Warburg Effect) and how it’s essential for the transformation of normal cells to cancer cells Examining how mitochondrial uncoupling provides a unique opportunity for effective treatment of these major…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.